6 unknown. 6 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 6 | Unknown 6 |
Follow NAFLD: new trials by email Literature Review of NAFLD trials Research Report on NAFLD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Multidisciplinary Design to Optimize Schizophrenia Treatment Based on Multi-omics Data and Systems Biology Analysis Aripiprazole, Paliperidone - Schizophrenia, Treatment-resistant Schizophrenia | Phase 4 | Unknown | Consorcio Centro de Investigación Biomédica en Red (CIBER) | 244 | 2023-11-01 | 2023-09-29 |
| A Study to Evaluate the Safety and Effectiveness of Saroglitazar 4 mg in Patients With NAFLD With Comorbidities Saroglitazar - NAFLD, Obesity | Phase 4 | Unknown | Zydus Lifesciences Limited | 1500 | 2023-07-20 | 2024-02-07 |
| Effect of Oral Anti-diabetic Medication on Liver Fat in Subjects With Type II Diabetes and Non-alcoholic Fatty Liver Pioglitazone, Empagliflozin, Pioglitazone + Empagliflozin - Diabetes Mellitus, Type 2, NASH - Nonalcoholic Steatohepatitis | Phase 4 | Unknown | Getz Pharma | 123 | 2021-09-15 | 2022-03-18 |
| The Effect of Consecutive Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease (NAFLD) Gut microbiome transplantation - NAFLD | Phase 4 | Unknown | Leiden University Medical Center | 20 | 2019-12-10 | 2020-07-09 |
| The Effect of Empagliflozin on NAFLD in Asian Patients With Type 2 Diabetes Empagliflozin - Type2 Diabetes, NAFLD | Phase 4 | Unknown | University of Malaya | 25 | 2016-11-01 | 2017-05-31 |
| Effect of Metadoxine on Oxidative Stress in Non-alcoholic Hepatic Steatosis Metadoxine - NAFLD, Pre-diabetes | Phase 4 | Unknown | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | 100 | 2016-01-01 | 2019-01-31 |
Non-alcoholic Fatty Liver Disease (6) · Diabetes Mellitus, Type 2 (2) · Diabetes Mellitus (1) · Dyslipidemias (1) · Glucose Intolerance (1) · Lipid Metabolism Disorders (1) · Metabolic Syndrome (1) · Obesity (1) · Psychotic Disorders (1) · Schizophrenia (1) · Schizophrenia, Treatment-Resistant (1)
Digestive System Diseases (6) · Fatty Liver (6) · Liver Diseases (6) · Glucose Metabolism Disorders (4) · Metabolic Diseases (4) · Nutritional and Metabolic Diseases (4) · Endocrine System Diseases (3) · Diabetes Mellitus (2) · Body Weight (1) · Hyperglycemia (1) · Hyperinsulinism (1) · Insulin Resistance (1) · Lipid Metabolism Disorders (1) · Mental Disorders (1) · Nutrition Disorders (1)
empagliflozin (2) · Aripiprazole (1) · Fecal Microbiota Transplantation (1) · Paliperidone Palmitate (1) · Pioglitazone (1) · metadoxine (1) · saroglitazar (1)
Consorcio Centro de Investigación Biomédica en Red (CIBER) (1) · Getz Pharma (1) · Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran (1) · Leiden University Medical Center (1) · University of Malaya (1) · Zydus Lifesciences Limited (1)
India (1) · Malaysia (1) · Mexico (1) · Netherlands (1) · Pakistan (1)
Aldo Torre, MD MSci (1) · Dr. Deven Parmar, MD,FCP (1) · Javier Labad Arias, MD, PhD (1) · Shireene R Vethakkan, MD (1)